Immunosuppressive Treatment Combined with Nucleoside Analogues Is Superior to Nucleoside Analogues Alone in the Treatment of Severe Thrombocytopenia in Patients with Cirrhosis-Associated with Hepatitis B in China: A Multicenter, Observational Study
机构:[1]Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China[2]Department of Hematology, Beijing Hospital, Ministry of Health Beijing China, Beijing, China[3]Department of Haematology, West China Hospital, West China School of Clinical Medicine, Sichuan University, Chengdu, China四川大学华西医院[4]Shandong provincial hospital, Beijing, Ghana[5]Union Hospital, Fujian Medical University, Fujian, China[6]First Affiliated Hospital, Xinjiang Medical University, Urumqi, China[7]Beijing Friendship Hospital, Beijing, China首都医科大学附属北京友谊医院[8]Beijing Tongren Hospital, Beijing, China首都医科大学附属北京同仁医院首都医科大学附属同仁医院[9]The People's Hospital of Peking University,Institute of Hepatic Diseases, Beijing, China
第一作者机构:[1]Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China
推荐引用方式(GB/T 7714):
Zhang Xiao-Hui,Feng Ru,Xu Lan-ping,et al.Immunosuppressive Treatment Combined with Nucleoside Analogues Is Superior to Nucleoside Analogues Alone in the Treatment of Severe Thrombocytopenia in Patients with Cirrhosis-Associated with Hepatitis B in China: A Multicenter, Observational Study[J].BLOOD.2014,124(21):
APA:
Zhang, Xiao-Hui,Feng, Ru,Xu, Lan-ping,Jiang, Qian,Jiang, Hao...&Huang, Xiao Jun.(2014).Immunosuppressive Treatment Combined with Nucleoside Analogues Is Superior to Nucleoside Analogues Alone in the Treatment of Severe Thrombocytopenia in Patients with Cirrhosis-Associated with Hepatitis B in China: A Multicenter, Observational Study.BLOOD,124,(21)
MLA:
Zhang, Xiao-Hui,et al."Immunosuppressive Treatment Combined with Nucleoside Analogues Is Superior to Nucleoside Analogues Alone in the Treatment of Severe Thrombocytopenia in Patients with Cirrhosis-Associated with Hepatitis B in China: A Multicenter, Observational Study".BLOOD 124..21(2014)